Clinical impact of upper endoscopy in the management of patients with gastroesophageal reflux disease

John M. Wo, Christian Mendez, Steve Harrell, Rauol Joubran, Phillip F. Bressoud, William Paul McKinney

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

OBJECTIVE: Esophago-gastro-duodenoscopy (EGD) is frequently performed in patients with heartburn. However, the benefit of an EGD is unclear. The objective is to determine the clinical impact of performing an EGD in the management of GERD. METHODS: Patients with alarm symptoms or persistent heartburn from primary care and gastroenterology clinics were invited to participate. Patients with known reflux complications or an EGD procedure within 3 yr were excluded. Endpoints for EGD-improving management were prospectively defined: change in medical therapy, dilating esophageal stricture, identifying Barrett's esophagus (BE), finding severe esophagitis (Hetzel-Dent grade 3 or 4), or finding cancer. RESULTS: Two hundred and six patients (59 M/147 F; median age, 48 yr) were enrolled, in which, 124 had alarm symptoms and 82 had persistent heartburn. EGD improved the overall management in 40% of patients with alarm symptoms and 29% with persistent heartburn (p = NS). Medical therapy was altered in only 5% of patients, and no cancer was identified. EGD was more likely to improve management in males with alarm symptoms. CONCLUSIONS: It was uncommon for an EGD to alter antireflux therapy. The management was improved in approximately one-third of the patients by dilating esophageal stricture, finding BE to initiate surveillance, or finding severe esophagitis. EGD should be performed when alarm symptoms are present, especially in males.

Original languageEnglish (US)
Pages (from-to)2311-2316
Number of pages6
JournalAmerican Journal of Gastroenterology
Volume99
Issue number12
DOIs
StatePublished - Dec 1 2004

Fingerprint

Duodenoscopy
Gastroesophageal Reflux
Endoscopy
Heartburn
Esophageal Stenosis
Barrett Esophagus
Esophagitis
Gastroenterology
Neoplasms
Primary Health Care
Therapeutics

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Clinical impact of upper endoscopy in the management of patients with gastroesophageal reflux disease. / Wo, John M.; Mendez, Christian; Harrell, Steve; Joubran, Rauol; Bressoud, Phillip F.; McKinney, William Paul.

In: American Journal of Gastroenterology, Vol. 99, No. 12, 01.12.2004, p. 2311-2316.

Research output: Contribution to journalArticle

Wo, John M. ; Mendez, Christian ; Harrell, Steve ; Joubran, Rauol ; Bressoud, Phillip F. ; McKinney, William Paul. / Clinical impact of upper endoscopy in the management of patients with gastroesophageal reflux disease. In: American Journal of Gastroenterology. 2004 ; Vol. 99, No. 12. pp. 2311-2316.
@article{90da33fa94294f40abf5b6931ef2e9a6,
title = "Clinical impact of upper endoscopy in the management of patients with gastroesophageal reflux disease",
abstract = "OBJECTIVE: Esophago-gastro-duodenoscopy (EGD) is frequently performed in patients with heartburn. However, the benefit of an EGD is unclear. The objective is to determine the clinical impact of performing an EGD in the management of GERD. METHODS: Patients with alarm symptoms or persistent heartburn from primary care and gastroenterology clinics were invited to participate. Patients with known reflux complications or an EGD procedure within 3 yr were excluded. Endpoints for EGD-improving management were prospectively defined: change in medical therapy, dilating esophageal stricture, identifying Barrett's esophagus (BE), finding severe esophagitis (Hetzel-Dent grade 3 or 4), or finding cancer. RESULTS: Two hundred and six patients (59 M/147 F; median age, 48 yr) were enrolled, in which, 124 had alarm symptoms and 82 had persistent heartburn. EGD improved the overall management in 40{\%} of patients with alarm symptoms and 29{\%} with persistent heartburn (p = NS). Medical therapy was altered in only 5{\%} of patients, and no cancer was identified. EGD was more likely to improve management in males with alarm symptoms. CONCLUSIONS: It was uncommon for an EGD to alter antireflux therapy. The management was improved in approximately one-third of the patients by dilating esophageal stricture, finding BE to initiate surveillance, or finding severe esophagitis. EGD should be performed when alarm symptoms are present, especially in males.",
author = "Wo, {John M.} and Christian Mendez and Steve Harrell and Rauol Joubran and Bressoud, {Phillip F.} and McKinney, {William Paul}",
year = "2004",
month = "12",
day = "1",
doi = "10.1111/j.1572-0241.2004.40502.x",
language = "English (US)",
volume = "99",
pages = "2311--2316",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Clinical impact of upper endoscopy in the management of patients with gastroesophageal reflux disease

AU - Wo, John M.

AU - Mendez, Christian

AU - Harrell, Steve

AU - Joubran, Rauol

AU - Bressoud, Phillip F.

AU - McKinney, William Paul

PY - 2004/12/1

Y1 - 2004/12/1

N2 - OBJECTIVE: Esophago-gastro-duodenoscopy (EGD) is frequently performed in patients with heartburn. However, the benefit of an EGD is unclear. The objective is to determine the clinical impact of performing an EGD in the management of GERD. METHODS: Patients with alarm symptoms or persistent heartburn from primary care and gastroenterology clinics were invited to participate. Patients with known reflux complications or an EGD procedure within 3 yr were excluded. Endpoints for EGD-improving management were prospectively defined: change in medical therapy, dilating esophageal stricture, identifying Barrett's esophagus (BE), finding severe esophagitis (Hetzel-Dent grade 3 or 4), or finding cancer. RESULTS: Two hundred and six patients (59 M/147 F; median age, 48 yr) were enrolled, in which, 124 had alarm symptoms and 82 had persistent heartburn. EGD improved the overall management in 40% of patients with alarm symptoms and 29% with persistent heartburn (p = NS). Medical therapy was altered in only 5% of patients, and no cancer was identified. EGD was more likely to improve management in males with alarm symptoms. CONCLUSIONS: It was uncommon for an EGD to alter antireflux therapy. The management was improved in approximately one-third of the patients by dilating esophageal stricture, finding BE to initiate surveillance, or finding severe esophagitis. EGD should be performed when alarm symptoms are present, especially in males.

AB - OBJECTIVE: Esophago-gastro-duodenoscopy (EGD) is frequently performed in patients with heartburn. However, the benefit of an EGD is unclear. The objective is to determine the clinical impact of performing an EGD in the management of GERD. METHODS: Patients with alarm symptoms or persistent heartburn from primary care and gastroenterology clinics were invited to participate. Patients with known reflux complications or an EGD procedure within 3 yr were excluded. Endpoints for EGD-improving management were prospectively defined: change in medical therapy, dilating esophageal stricture, identifying Barrett's esophagus (BE), finding severe esophagitis (Hetzel-Dent grade 3 or 4), or finding cancer. RESULTS: Two hundred and six patients (59 M/147 F; median age, 48 yr) were enrolled, in which, 124 had alarm symptoms and 82 had persistent heartburn. EGD improved the overall management in 40% of patients with alarm symptoms and 29% with persistent heartburn (p = NS). Medical therapy was altered in only 5% of patients, and no cancer was identified. EGD was more likely to improve management in males with alarm symptoms. CONCLUSIONS: It was uncommon for an EGD to alter antireflux therapy. The management was improved in approximately one-third of the patients by dilating esophageal stricture, finding BE to initiate surveillance, or finding severe esophagitis. EGD should be performed when alarm symptoms are present, especially in males.

UR - http://www.scopus.com/inward/record.url?scp=11144322774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144322774&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.2004.40502.x

DO - 10.1111/j.1572-0241.2004.40502.x

M3 - Article

C2 - 15571575

AN - SCOPUS:11144322774

VL - 99

SP - 2311

EP - 2316

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 12

ER -